PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
BAFF 1,240 Target Target BAFFR 44 33 0.14 -0.49 0.75 0.80
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
Epiregulin 291 Target Target beta-Cellulin 17 6 0.09 -0.80 0.35 0.80
D(1a) Dopamine Receptor 51 Target Target D(2) Dopamine Receptor 1,559 41 0.15 -0.44 0.80 0.80
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
CAMK2A 42 Target Target CAMK4 43 1 0.02 -0.98 0.02 0.80
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
CCL18 256 Target Target CCL1 220 9 0.04 -0.96 0.04 0.80
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
Aurora B kinase 415 Target Target Aurora A kinase 318 14 0.04 -0.96 0.04 0.79
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Alpha-Glucosidase 4,319 Target Target Lysosomal Alpha-Glucosidase 105 105 0.16 -0.10 1.00 0.79
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Angiomax (Bivalirudin)- FDA 13 Drug Target Bivalirudin 891 12 0.11 -0.28 0.92 0.79
Bivalirudin 891 Target Target Eptifibatide 772 36 0.04 -0.96 0.05 0.79
CCL7 274 Target Target CCL5 2,002 60 0.08 -0.87 0.22 0.79
ApoE2 517 Target Target APOE 12,771 454 0.18 -0.34 0.88 0.78
CCL7 274 Target Target CCL18 256 8 0.03 -0.97 0.03 0.78
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
EPHA2 532 Target Target EPHA3 140 13 0.05 -0.94 0.09 0.78
Cathepsin G 1,613 Target Target Alpha-1 AntiChymotrypsin 1,460 75 0.05 -0.95 0.05 0.78
EPHB4 329 Target Target EPHA3 140 8 0.04 -0.96 0.06 0.78
CCL3 1,427 Target Target CCL8 197 38 0.07 -0.89 0.19 0.78
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
Glutathione Peroxidase 2 67 Target Target Glutathione S-Transferase A2 25 1 0.02 -0.97 0.04 0.78
Retinitis 9,116 Disease Target ADRP 537 317 0.14 -0.63 0.59 0.78
CCL2 3,560 Target Target CCL8 197 92 0.11 -0.72 0.47 0.78
Beta-Glucosidase 4,297 Target Target Alpha-Glucosidase 4,319 261 0.06 -0.94 0.06 0.78
ELC 355 Target Target Ck-beta-11 4 3 0.08 -0.50 0.75 0.78
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
CCL5 2,002 Target Target CXCL2 750 73 0.06 -0.93 0.10 0.78
CXCL9 1,016 Target Target CXCL2 750 37 0.04 -0.96 0.05 0.78
EPHA2 532 Target Target EPHB1 137 12 0.04 -0.94 0.09 0.78
EPHA2 532 Target Target EPHB2 385 16 0.04 -0.96 0.04 0.78
CXCL11 526 Target Target CXCL3 145 12 0.04 -0.95 0.08 0.78
CXCL3 145 Target Target CCL1 220 5 0.03 -0.97 0.03 0.78
CXCL16 341 Target Target CXCL11 526 15 0.04 -0.96 0.04 0.78
Dihydropteroate Synthase 408 Target Target Dihydrofolate Reductase 5,563 166 0.11 -0.76 0.41 0.78
CXCL10 2,386 Target Target CXCL2 750 83 0.06 -0.93 0.11 0.78
CCL19 658 Target Target CXCL9 1,016 34 0.04 -0.96 0.05 0.78
CXCL7 76 Target Target Eotaxin-3/CCL26 26 1 0.02 -0.97 0.04 0.78
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
CCL4 5,638 Target Target CCL2 3,560 295 0.07 -0.93 0.08 0.78
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
CAPG 85 Target Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.78
CXCL16 341 Target Target CXCL9 1,016 26 0.04 -0.95 0.08 0.77
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
CCL19 658 Target Target CXCL11 526 19 0.03 -0.97 0.04 0.77
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
DNAJB1 44 Target Target CXCL3 145 2 0.03 -0.97 0.05 0.77
CCL18 256 Target Target CXCL3 145 5 0.03 -0.97 0.03 0.77
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
CD1A 2,739 Target Target CD14 9,941 456 0.09 -0.89 0.17 0.77
BAFFR 44 Target Target CD148 74 1 0.02 -0.98 0.02 0.77
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
CXCL11 526 Target Target CXCL2 750 21 0.03 -0.97 0.04 0.77
Deep Vein Thrombosis 10,952 Disease Target D-Dimer 6,185 630 0.08 -0.92 0.10 0.77
CXCL9 1,016 Target Target CCL21 808 32 0.04 -0.96 0.04 0.77
CCL18 256 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
CXCL9 1,016 Target Target CCL8 197 21 0.05 -0.94 0.11 0.77
BAFFR 44 Target Target BLyS 457 6 0.04 -0.92 0.14 0.77
Multidrug Resistance-Associated Protein 2 462 Target Target Multidrug Resistance Protein 1 495 13 0.03 -0.97 0.03 0.77
CXCL11 526 Target Target CCL1 220 11 0.03 -0.96 0.05 0.77
CCL18 256 Target Target CCL8 197 5 0.02 -0.98 0.03 0.77
CXCL16 341 Target Target CXCL7 76 5 0.03 -0.96 0.07 0.77
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
CCL7 274 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
CCL18 256 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
CXCL16 341 Target Target CXCL3 145 6 0.03 -0.97 0.04 0.77
EPHA4 357 Target Target EPHB4 329 8 0.02 -0.98 0.02 0.77
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
CCL7 274 Target Target CXCL11 526 11 0.03 -0.97 0.04 0.77
Aurora Kinase A 196 Target Target Aurora A kinase 318 6 0.02 -0.98 0.03 0.77
Aurora Kinase A 196 Target Target AURKC 26 2 0.03 -0.96 0.08 0.77
Glutaredoxin-1 142 Target Target Glutathione S-Transferase Mu 2 8 1 0.03 -0.93 0.12 0.77
FABP1 90 Target Target Carbonic Anhydrase 3 36 1 0.02 -0.98 0.03 0.77
CXCL16 341 Target Target CCL7 274 7 0.02 -0.98 0.03 0.77
APOA2 118 Target Target APOC1 126 2 0.02 -0.98 0.02 0.77